These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35370140)

  • 1. Characterizing and Quantifying Extrahepatic Metabolism of (-)-Δ
    Kumar AR; Patilea-Vrana GI; Anoshchenko O; Unadkat JD
    Drug Metab Dispos; 2022 Jun; 50(6):734-740. PubMed ID: 35370140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying Hepatic Enzyme Kinetics of (-)-∆
    Patilea-Vrana GI; Unadkat JD
    Drug Metab Dispos; 2019 Jul; 47(7):743-752. PubMed ID: 31048453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic Enzymes Relevant to the Disposition of (-)-∆
    Patilea-Vrana GI; Anoshchenko O; Unadkat JD
    Drug Metab Dispos; 2019 Mar; 47(3):249-256. PubMed ID: 30567877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP2C9, CYP3A and CYP2C19 metabolize Δ9-tetrahydrocannabinol to multiple metabolites but metabolism is affected by human liver fatty acid binding protein (FABP1).
    Yabut KCB; Winnie Wen Y; Simon KT; Isoherranen N
    Biochem Pharmacol; 2024 Oct; 228():116191. PubMed ID: 38583809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Verification of a Linked
    Patilea-Vrana GI; Unadkat JD
    Drug Metab Dispos; 2021 Jul; 49(7):509-520. PubMed ID: 33952608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of human hepatic and extrahepatic UDP-glucuronosyltransferase enzymes involved in the metabolism of classic cannabinoids.
    Mazur A; Lichti CF; Prather PL; Zielinska AK; Bratton SM; Gallus-Zawada A; Finel M; Miller GP; Radomińska-Pandya A; Moran JH
    Drug Metab Dispos; 2009 Jul; 37(7):1496-504. PubMed ID: 19339377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal Physiologically Based Pharmacokinetic Model of Intravenously and Orally Administered Delta-9-Tetrahydrocannabinol in Healthy Volunteers.
    Wolowich WR; Greif R; Kleine-Brueggeney M; Bernhard W; Theiler L
    Eur J Drug Metab Pharmacokinet; 2019 Oct; 44(5):691-711. PubMed ID: 31114948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes.
    Watanabe K; Yamaori S; Funahashi T; Kimura T; Yamamoto I
    Life Sci; 2007 Mar; 80(15):1415-9. PubMed ID: 17303175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Predictions of Cytochrome P450 (P450)-Mediated In Vivo Cannabinoid-Drug Interactions Based on Reversible and Time-Dependent P450 Inhibition in Human Liver Microsomes.
    Bansal S; Paine MF; Unadkat JD
    Drug Metab Dispos; 2022 Apr; 50(4):351-360. PubMed ID: 35115300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of pregnancy and associated hormones on the pharmacokinetics of Δ
    Authement AK; Isoherranen N
    Expert Opin Drug Metab Toxicol; 2024; 20(1-2):73-93. PubMed ID: 38258511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of phase II metabolism of 11-hydroxy-Δ-9-tetrahydrocannabinol and metabolite verification by chemical synthesis of 11-hydroxy-Δ-9-tetrahydrocannabinol-glucuronide.
    Hassenberg C; Clausen F; Hoffmann G; Studer A; Schürenkamp J
    Int J Legal Med; 2020 Nov; 134(6):2105-2119. PubMed ID: 32808050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Characterization of Ertugliflozin Metabolism by UDP-Glucuronosyltransferase and Cytochrome P450 Enzymes.
    Lapham K; Callegari E; Cianfrogna J; Lin J; Niosi M; Orozco CC; Sharma R; Goosen TC
    Drug Metab Dispos; 2020 Dec; 48(12):1350-1363. PubMed ID: 33020067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP3A4 is a major isoform responsible for oxidation of 7-hydroxy-Delta(8)-tetrahydrocannabinol to 7-oxo-delta(8)-tetrahydrocannabinol in human liver microsomes.
    Matsunaga T; Kishi N; Higuchi S; Watanabe K; Ohshima T; Yamamoto I
    Drug Metab Dispos; 2000 Nov; 28(11):1291-6. PubMed ID: 11038155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions.
    Nasrin S; Watson CJW; Perez-Paramo YX; Lazarus P
    Drug Metab Dispos; 2021 Dec; 49(12):1070-1080. PubMed ID: 34493602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450-Catalyzed Metabolism of Cannabidiol to the Active Metabolite 7-Hydroxy-Cannabidiol.
    Beers JL; Fu D; Jackson KD
    Drug Metab Dispos; 2021 Oct; 49(10):882-891. PubMed ID: 34330718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Intoxication Equivalency of 11-Hydroxy-Δ
    Zagzoog A; Halter K; Jones AM; Bannatyne N; Cline J; Wilcox A; Smolyakova AM; Laprairie RB
    J Pharmacol Exp Ther; 2024 Oct; 391(2):194-205. PubMed ID: 38858091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species Difference in the Metabolism of Mulberrin in Vitro and Its Inhibitory Effect on Cytochrome P450 and UDP-Glucuronosyltransferase Enzymes.
    Hu J; Hu T; Guo Z; Song Y; Shan L; Shi X
    Chem Pharm Bull (Tokyo); 2022; 70(10):669-678. PubMed ID: 36184449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex difference in the oxidative metabolism of delta 9-tetrahydrocannabinol in the rat.
    Narimatsu S; Watanabe K; Yamamoto I; Yoshimura H
    Biochem Pharmacol; 1991 Apr; 41(8):1187-94. PubMed ID: 1848985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of repeated administration of 11-hydroxy-delta 8-tetrahydrocannabinol, an active metabolite of delta 8-tetrahydrocannabinol, on the hepatic microsomal drug-metabolizing enzyme system of mice.
    Watanabe K; Arai M; Narimatsu S; Yamamoto I; Yoshimura H
    Biochem Pharmacol; 1986 Jun; 35(11):1861-5. PubMed ID: 3013200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-drug interaction (DDI) assessments of ruxolitinib, a dual substrate of CYP3A4 and CYP2C9, using a verified physiologically based pharmacokinetic (PBPK) model to support regulatory submissions.
    Umehara K; Huth F; Jin Y; Schiller H; Aslanis V; Heimbach T; He H
    Drug Metab Pers Ther; 2019 May; 34(2):. PubMed ID: 31145690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.